Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. (2018)

First Author: Wang Z
Attributed to:  Tracking hydrogel therapeutics using quantitative whole-body imaging funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-018-0573-2

PubMed Identifier: 29795262

Publication URI: http://europepmc.org/abstract/MED/29795262

Type: Journal Article/Review

Volume: 9

Parent Publication: Cell death & disease

Issue: 6